Shoncef-S 1000mg/500mg Injection
Marketer
Reco Drugs
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Shoncef-S 1000mg/500mg Injection
Cefixime/Sulbactam 1000mg/500mg injection is a dual-action antibiotic. It's used to combat a range of bacterial infections by inhibiting microbial proliferation and preventing infection spread. Administration must be overseen by a medical practitioner. Strictly adhere to the prescribed dosage schedule; complete the full course, even with symptom improvement, as premature cessation can compromise efficacy. Possible side effects include nausea, vomiting, diarrhea, and digestive upset. Report worsening symptoms immediately. Seek urgent medical attention for allergic reactions (skin rashes, itching, swelling, breathing difficulties). Inform your physician of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption may intensify drowsiness. While generally safe for driving, refrain from operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medication's impact.
Uses of Shoncef-S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Shoncef-S 1000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Shoncef-S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Shoncef-S 1000mg/500mg Injection:
Administering this medication will be done by your physician or their qualified staff; self-medication is strictly prohibited.
How Shoncef-S 1000mg/500mg Injection works:
The injectable drug Shoncef-S (1000mg/500mg) unites ceftriaxone, a bacterial growth inhibitor, with sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Sulbactam counters bacterial resistance, thus augmenting ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
The concurrent use of Shoncef-S 1000mg/500mg Injection and alcohol poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Shoncef-S (1000mg/500mg) is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
The administration of Shoncef-S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Shoncef-S 1000mg/500mg Injection can potentially reduce awareness, impair vision, and induce drowsiness or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Shoncef-S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
The injectable medication Shoncef-S (1000mg/500mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alterations for Shoncef-S (1000mg/500mg) injection are not advised for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Shoncef-S 1000mg/500mg Injection :
Should you forget a scheduled dose of Shoncef-S 1000mg/500mg Injection, seek medical advice immediately.
Facts to Know About Shoncef-S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Anti-Infective Agents |
3,018 People bought this recently